Skip to main content
Erschienen in: Clinical and Experimental Medicine 4/2017

30.11.2016 | Original Article

New single nucleotide polymorphisms (SNPs) in homologous recombination repair genes detected by microarray analysis in Polish breast cancer patients

verfasst von: Hanna Romanowicz, Dominik Strapagiel, Marcin Słomka, Marta Sobalska-Kwapis, Ewa Kępka, Anna Siewierska-Górska, Marek Zadrożny, Jan Bieńkiewicz, Beata Smolarz

Erschienen in: Clinical and Experimental Medicine | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer is the most common cause of malignancy and mortality in women worldwide. This study aimed at localising homologous recombination repair (HR) genes and their chromosomal loci and correlating their nucleotide variants with susceptibility to breast cancer. In this study, authors analysed the association between single nucleotide polymorphisms (SNPs) in homologous recombination repair genes and the incidence of breast cancer in the population of Polish women. Blood samples from 94 breast cancer patients were analysed as test group. Individuals were recruited into the study at the Department of Oncological Surgery and Breast Diseases of the Institute of the Polish Mother’s Memorial Hospital in Lodz, Poland. Healthy controls (n = 500) were obtained from the Biobank Laboratory, Department of Molecular Biophysics, University of Lodz. Then, DNA of breast cancer patients was compared with one of the disease-free women. The test was supported by microarray analysis. Statistically significant correlations were identified between breast cancer and 3 not described previously SNPs of homologous recombination repair genes BRCA1 and BRCA2: rs59004709, rs4986852 and rs1799950. Further studies on larger groups are warranted to support the hypothesis of correlation between the abovementioned genetic variants and breast cancer risk.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.CrossRefPubMed Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.CrossRefPubMed
3.
Zurück zum Zitat Aloyz R, Xu ZY, Bello V, et al. Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD. Cancer Res. 2002;62:5457–62.PubMed Aloyz R, Xu ZY, Bello V, et al. Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD. Cancer Res. 2002;62:5457–62.PubMed
4.
Zurück zum Zitat Liu C, Zhou S, Begum S, et al. Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer. Lung Cancer. 2007;55:303–11.CrossRefPubMed Liu C, Zhou S, Begum S, et al. Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer. Lung Cancer. 2007;55:303–11.CrossRefPubMed
5.
Zurück zum Zitat Xu ZY, Loignon M, Han FY, Panasci L, Aloyz R. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis. J Pharmacol Exp Ther. 2005;314:495–505.CrossRefPubMed Xu ZY, Loignon M, Han FY, Panasci L, Aloyz R. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis. J Pharmacol Exp Ther. 2005;314:495–505.CrossRefPubMed
6.
Zurück zum Zitat Ganguly A, Shields CL. Differential gene expression profile of retinoblastoma compared to normal retina. Mol Vis. 2010;16:1292–303.PubMedPubMedCentral Ganguly A, Shields CL. Differential gene expression profile of retinoblastoma compared to normal retina. Mol Vis. 2010;16:1292–303.PubMedPubMedCentral
7.
Zurück zum Zitat Kauffmann A, Rosselli F, Lazar V, et al. High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene. 2008;27:565–73.CrossRefPubMed Kauffmann A, Rosselli F, Lazar V, et al. High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene. 2008;27:565–73.CrossRefPubMed
8.
Zurück zum Zitat Sarasin A, Dessen P. DNA repair pathways and human metastatic malignant melanoma. Curr Mol Med. 2010;10:413–8.CrossRefPubMed Sarasin A, Dessen P. DNA repair pathways and human metastatic malignant melanoma. Curr Mol Med. 2010;10:413–8.CrossRefPubMed
9.
Zurück zum Zitat Davidson JM, Gorringe KL, Chin SF, et al. Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer. 2006;83:1309–17.CrossRef Davidson JM, Gorringe KL, Chin SF, et al. Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer. 2006;83:1309–17.CrossRef
10.
Zurück zum Zitat Forozan F, Mahlamaki EH, Monni O, et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res. 2000;60:4519–25.PubMed Forozan F, Mahlamaki EH, Monni O, et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res. 2000;60:4519–25.PubMed
11.
Zurück zum Zitat Kytola S, Rummukainen J, Nordgren A, et al. Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer. 2000;28:308–17.CrossRefPubMed Kytola S, Rummukainen J, Nordgren A, et al. Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer. 2000;28:308–17.CrossRefPubMed
12.
Zurück zum Zitat Loveday RL, Greenman J, Simcox DL, et al. Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer. 2000;86:494–500.CrossRefPubMed Loveday RL, Greenman J, Simcox DL, et al. Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer. 2000;86:494–500.CrossRefPubMed
13.
Zurück zum Zitat Vijg J, Dolle MET. Large genome rearrangements as a primary cause of aging. Mech Ageing Dev. 2002;123:907–15.CrossRefPubMed Vijg J, Dolle MET. Large genome rearrangements as a primary cause of aging. Mech Ageing Dev. 2002;123:907–15.CrossRefPubMed
14.
Zurück zum Zitat Bahar R, Hartmann CH, Rodriguez KA, et al. Increased cell-to-cell variation in gene expression in ageing mouse heart. Nature. 2006;441:1011–4.CrossRefPubMed Bahar R, Hartmann CH, Rodriguez KA, et al. Increased cell-to-cell variation in gene expression in ageing mouse heart. Nature. 2006;441:1011–4.CrossRefPubMed
15.
Zurück zum Zitat Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis. 2002;23:687–96.CrossRefPubMed Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis. 2002;23:687–96.CrossRefPubMed
16.
Zurück zum Zitat Helleday T. Pathways for mitotic homologous recombination in mammalian cells. Mutat Res. 2003;532:103–15.CrossRefPubMed Helleday T. Pathways for mitotic homologous recombination in mammalian cells. Mutat Res. 2003;532:103–15.CrossRefPubMed
17.
Zurück zum Zitat Silva SN, Tomar M, Paulo C, et al. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiol. 2010;34:85–92.CrossRefPubMed Silva SN, Tomar M, Paulo C, et al. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiol. 2010;34:85–92.CrossRefPubMed
18.
Zurück zum Zitat Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999;59:2557–61.PubMed Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999;59:2557–61.PubMed
19.
Zurück zum Zitat Strapagiel D, Sobalska-Kwapis M, Słomka M, Marciniak B. Biobank Lodz—DNA based biobank at the University of Lodz, Poland, Open J Bioresour. 2016, in press. Strapagiel D, Sobalska-Kwapis M, Słomka M, Marciniak B. Biobank Lodz—DNA based biobank at the University of Lodz, Poland, Open J Bioresour. 2016, in press.
20.
Zurück zum Zitat Strapagiel D, Majewska M, Słomka M, Janik K, Sobalska M, Bartosz G. Method for determining sex, involves utilizing melting profile analysis technique, and obtaining specific fragments of DNA by PCR-based DNA from samples of human biological material. Patent Number(s): PL406569-A1, 2015. Strapagiel D, Majewska M, Słomka M, Janik K, Sobalska M, Bartosz G. Method for determining sex, involves utilizing melting profile analysis technique, and obtaining specific fragments of DNA by PCR-based DNA from samples of human biological material. Patent Number(s): PL406569-A1, 2015.
21.
Zurück zum Zitat Purcell S, Neale B, Todd-Brown K, et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet. 2007;81:559–75.CrossRefPubMedPubMedCentral Purcell S, Neale B, Todd-Brown K, et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet. 2007;81:559–75.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Parshad R, Price FM, Bohr VA, Cowans KH, Zujewski JA, Sanford KK. Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer. 1996;74:1–5.CrossRefPubMedPubMedCentral Parshad R, Price FM, Bohr VA, Cowans KH, Zujewski JA, Sanford KK. Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer. 1996;74:1–5.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomark Prev. 2003;12:689–98. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomark Prev. 2003;12:689–98.
24.
Zurück zum Zitat Xie H, Xia K, Rong H, Chen X. Genetic polymorphism in hOGG1 is associated with triple-negative breast cancer risk in Chinese Han women. Breast. 2013;22:707–12.CrossRefPubMed Xie H, Xia K, Rong H, Chen X. Genetic polymorphism in hOGG1 is associated with triple-negative breast cancer risk in Chinese Han women. Breast. 2013;22:707–12.CrossRefPubMed
25.
Zurück zum Zitat Gross E, Meul C, Raab S, et al. Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers. Br J Cancer. 2013;109:2347–55.CrossRefPubMedPubMedCentral Gross E, Meul C, Raab S, et al. Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers. Br J Cancer. 2013;109:2347–55.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Smolarz B, Makowska M, Samulak D, et al. Single nucleotide polymorphisms (SNPs) of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women. Tumour Biol. 2014;35:3495–502.CrossRefPubMedPubMedCentral Smolarz B, Makowska M, Samulak D, et al. Single nucleotide polymorphisms (SNPs) of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women. Tumour Biol. 2014;35:3495–502.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Smolarz B, Zadrożny M, Duda-Szymańska J, et al. RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women. Pol J Pathol. 2013;64:39–43.CrossRefPubMed Smolarz B, Zadrożny M, Duda-Szymańska J, et al. RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women. Pol J Pathol. 2013;64:39–43.CrossRefPubMed
28.
Zurück zum Zitat Kennedy RD, D’Andrea AD. The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev. 2005;19:2925–40.CrossRefPubMed Kennedy RD, D’Andrea AD. The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev. 2005;19:2925–40.CrossRefPubMed
29.
Zurück zum Zitat San Filippo J, Sung P, Klein H. Mechanism of eukaryotic homologous recombination. Annu Rev Biochem. 2008;77:229–57.CrossRefPubMed San Filippo J, Sung P, Klein H. Mechanism of eukaryotic homologous recombination. Annu Rev Biochem. 2008;77:229–57.CrossRefPubMed
30.
Zurück zum Zitat Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett. 2005;219:125–35.CrossRefPubMed Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett. 2005;219:125–35.CrossRefPubMed
31.
Zurück zum Zitat Kadouri L, Kote-Jarai Z, Hubert A, et al. A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers. Br J Cancer. 2004;90:2002–5.CrossRefPubMedPubMedCentral Kadouri L, Kote-Jarai Z, Hubert A, et al. A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers. Br J Cancer. 2004;90:2002–5.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Hosseini M, Houshmand M, Ebrahimi A. RAD51 polymorphisms and breast cancer risk. Mol Biol Rep. 2013;40:665–8.CrossRefPubMed Hosseini M, Houshmand M, Ebrahimi A. RAD51 polymorphisms and breast cancer risk. Mol Biol Rep. 2013;40:665–8.CrossRefPubMed
33.
Zurück zum Zitat Romanowicz-Makowska H, Smolarz B, Zadrozny M, et al. The association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland. Eur J Gynaecol Oncol. 2012;33:145–50.PubMed Romanowicz-Makowska H, Smolarz B, Zadrozny M, et al. The association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland. Eur J Gynaecol Oncol. 2012;33:145–50.PubMed
34.
Zurück zum Zitat Han J, Hankinson SE, Zhang SM. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13:520–4.CrossRefPubMed Han J, Hankinson SE, Zhang SM. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13:520–4.CrossRefPubMed
35.
Zurück zum Zitat Costa S, Pinto D, Pereira D, et al. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat. 2007;103:209–17.CrossRefPubMed Costa S, Pinto D, Pereira D, et al. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat. 2007;103:209–17.CrossRefPubMed
36.
Zurück zum Zitat Sangrajrang S, Schmezer P, Burkholder I, et al. The XRCC3 Thr241Met polymorphism and breast cancer risk: a case control study in a Thai population. Biomarkers. 2007;12:523–32.CrossRefPubMed Sangrajrang S, Schmezer P, Burkholder I, et al. The XRCC3 Thr241Met polymorphism and breast cancer risk: a case control study in a Thai population. Biomarkers. 2007;12:523–32.CrossRefPubMed
37.
Zurück zum Zitat Economopoulos KP, Sergentanis TN. XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;121:439–43.CrossRefPubMed Economopoulos KP, Sergentanis TN. XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;121:439–43.CrossRefPubMed
38.
Zurück zum Zitat Zhang J, Powell SN. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res. 2005;3:531–9.CrossRefPubMed Zhang J, Powell SN. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res. 2005;3:531–9.CrossRefPubMed
39.
Zurück zum Zitat Parvin S, Islam MS, Al-Mamun MM, et al. Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population. Breast Cancer. 2016;. doi:10.1007/s12282-016-0692.PubMed Parvin S, Islam MS, Al-Mamun MM, et al. Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population. Breast Cancer. 2016;. doi:10.​1007/​s12282-016-0692.PubMed
40.
Zurück zum Zitat Basu NN, Ingham S, Hodson J, et al. Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis. Fam Cancer. 2015;14:531–8.CrossRefPubMed Basu NN, Ingham S, Hodson J, et al. Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis. Fam Cancer. 2015;14:531–8.CrossRefPubMed
42.
Zurück zum Zitat Hartman AR, Ford JM. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat Genet. 2002;32:180–4.CrossRefPubMed Hartman AR, Ford JM. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat Genet. 2002;32:180–4.CrossRefPubMed
43.
44.
Zurück zum Zitat Ledwoń JK, Hennig EE, Maryan N, et al. Common low-penetrance risk variants associated with breast cancer in Polish women. BMC Cancer. 2013;13:510.CrossRefPubMedPubMedCentral Ledwoń JK, Hennig EE, Maryan N, et al. Common low-penetrance risk variants associated with breast cancer in Polish women. BMC Cancer. 2013;13:510.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Kluska A, Balabas A, Paziewska A, et al. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing. BMC Med Genomics. 2015;8:19.CrossRefPubMedPubMedCentral Kluska A, Balabas A, Paziewska A, et al. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing. BMC Med Genomics. 2015;8:19.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Jakubowska A, Gronwald J, Menkiszak J, et al. The RAD51 135 G > C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2007;16:270–5.CrossRefPubMed Jakubowska A, Gronwald J, Menkiszak J, et al. The RAD51 135 G > C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2007;16:270–5.CrossRefPubMed
47.
Zurück zum Zitat Jakubowska A, Gronwald J, Menkiszak J, et al. Hamann UBRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat. 2010;119:201–11.CrossRefPubMed Jakubowska A, Gronwald J, Menkiszak J, et al. Hamann UBRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat. 2010;119:201–11.CrossRefPubMed
Metadaten
Titel
New single nucleotide polymorphisms (SNPs) in homologous recombination repair genes detected by microarray analysis in Polish breast cancer patients
verfasst von
Hanna Romanowicz
Dominik Strapagiel
Marcin Słomka
Marta Sobalska-Kwapis
Ewa Kępka
Anna Siewierska-Górska
Marek Zadrożny
Jan Bieńkiewicz
Beata Smolarz
Publikationsdatum
30.11.2016
Verlag
Springer International Publishing
Erschienen in
Clinical and Experimental Medicine / Ausgabe 4/2017
Print ISSN: 1591-8890
Elektronische ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-016-0441-2

Weitere Artikel der Ausgabe 4/2017

Clinical and Experimental Medicine 4/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.